carlevo 25 mg/100 mg
orion corporation, fínsko - levodopa a inhibítory dekarboxylázy - 27 - antiparkinsonica
ontilyv
bial portela & companhia s.a. - opicapone - parkinsonova choroba - antiparkinsonické lieky - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
trigelan 100 mg/25 mg/200 mg filmom obalené tablety
gl pharma gmbh, rakúsko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
nakom mite 100 mg/25 mg
sandoz pharmaceuticals d.d., slovinsko - levodopa a inhibítory dekarboxylázy - 27 - antiparkinsonica
nakom 250 mg/25 mg
sandoz pharmaceuticals d.d., slovinsko - levodopa a inhibítory dekarboxylázy - 27 - antiparkinsonica
isicom 250 mg/25 mg
desitin arzneimitttel gmbh, nemecko - levodopa a inhibítory dekarboxylázy - 27 - antiparkinsonica
isicom 100 mg/25 mg
desitin arzneimitttel gmbh, nemecko - levodopa a inhibítory dekarboxylázy - 27 - antiparkinsonica
stalemed 200 mg/50 mg/200 mg
cande s.r.o., slovensko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
stalemed 150 mg/37,5 mg/200 mg
cande s.r.o., slovensko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
stalemed 100 mg/25 mg/200 mg
cande s.r.o., slovensko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica